Increased Tgf-β1 production by rat osteoblasts in the presence of PepGen P-15 in vitro

Journal of Endodontics

Volumn 30, Issue 4, 2004, Pages 213-217

  Trasatti, Candice ^a   Spears, Robert ^a   Gutmann, James L ^a   Opperman, Lynne A ^a  

^a BAYLOR COLLEGE OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL; INTERLEUKIN 1BETA; TRANSFORMING GROWTH FACTOR BETA1; BIO OSS; BIO-OSS; INTERLEUKIN 1; MINERAL; OSTEOGRAF N; OSTEOGRAF-N; PEPGEN P 15; PEPGEN P-15; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE REMODELING; BONE TRANSPLANTATION; CELL ACTIVATION; CELL ACTIVITY; CELL CULTURE; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDODONTICS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; MINERALIZATION; NONHUMAN; OSTEOBLAST; PERIODONTICS; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SYNTHESIS; RAT; SUPERNATANT; TOOTH IMPLANTATION; ANALYSIS OF VARIANCE; ANIMAL; BIOSYNTHESIS; BONE PROSTHESIS; DRUG EFFECT; METABOLISM; NONPARAMETRIC TEST; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BONE SUBSTITUTES; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1; MINERALS; OSTEOBLASTS; RATS; RATS, SPRAGUE-DAWLEY; STATISTICS, NONPARAMETRIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 2442695140     PISSN: 00992399     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004770-200404000-00007     Document Type: Article

References (32)

1. Andreasen JO, Rud J. Modes of healing histologically after endodontic surgery in 70 cases. Int J Oral Surg 1972;1:148-60.
2. Cochran DL, Wozney JM. Biological mediators for periodontal regeneration. Periodontol 2000 1999;19:40-58.
3. Hiatt WH, Schallhorn RG. Intraoral transplants of cancellous bone and marrow in periodontal lesions. J Periodontol 1973;44:194-208.
4. Aichelmann-Reidy ME, Yukna RA. Bone replacement grafts- the bone substitutes. Dent Clin North Am 1998;42:491-503.
5. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Multicenter clinical evaluation of combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell binding peptide (P-15) as a bone replacement graft material in human periodontal osseous defects: 6-month results. J Periodontol 2000;71:1671-9.
6. Yukna RA, Krauser JT, Callan DP, Evans GH, Cruz R, Martin M. Thirty-six month follow-up of 25 patients treated with combination anorganic bovine-derived hydroxyapatite matrix (ABM)/cell-binding peptide (P-15) bone replacement grafts in human infrabony defects, I: clinical findings. J Periodontol 2002;73:123-8.
7. Hollinger J, Wong ME. The integrated processes of hard tissue regeneration with special emphasis on fracture healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:594-606.
8. Postlethwaite AE, Keski-Oja J, Moses HL, Kang AH. Stimulation of the chemotactic migration of human fibroblasts by transforming growth factor β. J Exp Med 1987;165:251-6.
9. Wahl SM, Hunt DA, Wakefield LM, et al. Transforming growth factor β induces monocyte chemotaxis and growth factor production. Proc Natl Acad Sci U S A 1987;84:5788-92.
10. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth factor β gene family members and bone. Endocr Rev 1994;15:27-39.
11. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-61.
12. Centrella M, McCarthy TL, Canalis E. Transforming growth factor β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone. J Biol Chem 1987;262:2869-74.
13. Centrella CM, Massague J, Canalis E. Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 1986;119:2306-12.
14. Stashenko P, Dewhirst FE, Rooney ML, Desjardins LA, Heeley JD. Interlukin-1-α is a potent inhibitor of bone formation in vitro. J Bone Miner Res 1987;2:559-65.
15. Tocci MJ, Schmidt JA. Interlukin-1: structure and function. In: Cytokines in health and disease. Remick DG, Friedland JS, eds. New York: Marcel Dekker, 1997:1-27.
16. Espevik T, Figari IS, Shalaby R, et al. Inhibition of cytokine production by cyclosporin A and transforming growth factor β. J Exp Med 1987;166:571-6.
17. Williams DC, Boder GB, Toomey RE, et al. Mineralization and metabolic response in serially passaged adult rat bone cells. Calc Tissue Int 1980;30:233-46.
18. Opperman LA, Passarelli RW, Morgan EP, Reintjes M, Ogle RC. Tissue interactions with dura mater enable fetal cranial sutures to resist osseous obliteration in vitro. J Bone Miner Res 1995;10:1978-87.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-75.
20. McCulloch CAG. Basic considerations in periodontal wound healing to achieve regeneration. Periodontol 2000 1993;1:16-25.
21. Vilcek J. The cytokines: an overview. In: The cytokine handbook. Thompson A, ed. San Diego: Academic Press Limited, 1998:11-20.
22. Lallier TE, Yukna R, St Marie S, Moses R. The putative collagen binding hastens periodontal ligament cell attachment to bone replacement graft materials. J Periodontol 2001;72:990-7.
23. Qian JJ, Bhatnagar RS. Enhanced cell attachment to anorganic bone mineral in the presence of a synthetic peptide related to collagen. J Biomed Mater Res 1996;31:545-54.
24. Bhatnagar RS, Qian JJ, Wedrychowska A, Sadeghi M, Wu YM, Smith N. Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen. Tissue Engl 1999;5:53-65.
25. Derynck R, Choy L. Transforming growth factor-β and its receptors. In: The cytokine handbook. Thompson A, ed. San Diego: Academic Press Limited, 1998:593-636.
26. Gajdusek CM, Luo Z, Mayberg MR. Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J Cell Physiol 1993;157:33-44.
27. Liotta LA, Falanga V, Kehrl JH, Fauci AS. Transforming growth factor β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A 1986;83:4167-71.
28. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991;9:271-96.
29. Kehrl JH, Roberts AB, Wakefied LM, Jakowlew S, Sporn MB, Fauci AS. Transforming growth factor-β is an important immunomodulating protein for human B-lymphocytes. J Immunol 1986;137:3855-60.
30. Bonewald LF, Schwartz Z, Swain LD, Ramirez V, Poser J, Boyan BD. Stimulation of plasma membrane and matrix vesicle enzyme activity by transforming growth factor-beta in osteosarcoma cell cultures. J Cell Physiol 1990;145:200-6.
31. Centrella M, Ji C, Casinghino S, McCarthy TL. Rapid flux in transforming growth factor-beta receptors on bone cells. J Biol Chem 1996;271:18616-22.
32. Opperman LA, Galanis V, Williams AR, Adab K. Transforming growth factor-beta 3 (Tgf-β3) down-regulates Tgf-β receptor type I (Tβr-I) during rescue of cranial sutures from osseous obliteration. Ortho Craniofac Res 2002;5:5-16.